ArticleThe international journal of cardiovascular imaging2026
Predictors and prognostic impact of dynamic left ventricular outflow tract obstruction during dobutamine stress echocardiography.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDynamic left ventricular outflow tract obstruction (DLVOTO) is a recognized phenomenon during dobutamine stress echocardiography (DSE), but its predictors and long-term prognostic significance remain uncertain.
objectivesTo identify clinical and echocardiographic predictors of DLVOTO during DSE and to assess the association between DLVOTO and major adverse cardiovascular events (MACE).
methodsWe conducted a retrospective, single-center study included 355 consecutive patients undergoing DSE for ischemia assessment. DLVOTO was defined as a peak left ventricular outflow tract gradient ≥ 30 mmHg on continuous-wave Doppler. Clinical, echocardiographic, and stress-related variables were analyzed. The primary outcome was 3-point MACE (cardiovascular death, non-fatal myocardial infarction, or hospitalization for heart failure) during two-year follow-up. Multivariable logistic regression was used to identify independent predictors of DLVOTO and MACE.
resultsDLVOTO occurred in 48 patients (13.5%). Compared with patients without DLVOTO, those with DLVOTO were more frequently female and had higher baseline left ventricular ejection fraction and less frequent beta-blocker use and known coronary artery disease. During stress, they experienced more symptoms and arrhythmias but fewer positive ischemia tests. Female sex, higher baseline left ventricular ejection fraction, increased basal septal thickness, and absence of beta-blocker therapy were independent predictors of DLVOTO. During follow-up, DLVOTO was not independently associated with MACE, whereas chronic kidney disease and a positive ischemia test predicted adverse events.
conclusionsDLVOTO during DSE is relatively frequent and associated with identifiable clinical and echocardiographic predictors but does not confer an increased risk of major adverse cardiovascular events at two years.
Indexed as
Identifiers
41870766What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.